Suppr超能文献

胰岛素样生长因子-I信号通路在肌肉与骨骼相互作用中的作用。

Role of IGF-I signaling in muscle bone interactions.

作者信息

Bikle Daniel D, Tahimic Candice, Chang Wenhan, Wang Yongmei, Philippou Anastassios, Barton Elisabeth R

机构信息

VA Medical Center and University of California San Francisco, San Francisco, CA, USA.

National and Kapodistrian University of Athens, Department of Physiology, Medical School, Goudi-Athens, Greece.

出版信息

Bone. 2015 Nov;80:79-88. doi: 10.1016/j.bone.2015.04.036.

Abstract

Skeletal muscle and bone rely on a number of growth factors to undergo development, modulate growth, and maintain physiological strength. A major player in these actions is insulin-like growth factor I (IGF-I). However, because this growth factor can directly enhance muscle mass and bone density, it alters the state of the musculoskeletal system indirectly through mechanical crosstalk between these two organ systems. Thus, there are clearly synergistic actions of IGF-I that extend beyond the direct activity through its receptor. This review will cover the production and signaling of IGF-I as it pertains to muscle and bone, the chemical and mechanical influences that arise from IGF-I activity, and the potential for therapeutic strategies based on IGF-I. This article is part of a Special Issue entitled "Muscle Bone Interactions".

摘要

骨骼肌和骨骼依靠多种生长因子来进行发育、调节生长并维持生理强度。胰岛素样生长因子I(IGF-I)是这些过程中的一个主要参与者。然而,由于这种生长因子能够直接增加肌肉质量和骨密度,它通过这两个器官系统之间的机械相互作用间接改变肌肉骨骼系统的状态。因此,IGF-I显然存在超越其通过受体的直接活性的协同作用。本综述将涵盖与肌肉和骨骼相关的IGF-I的产生和信号传导、IGF-I活性产生的化学和机械影响,以及基于IGF-I的治疗策略的潜力。本文是名为“肌肉与骨骼相互作用”的特刊的一部分。

相似文献

1
Role of IGF-I signaling in muscle bone interactions.
Bone. 2015 Nov;80:79-88. doi: 10.1016/j.bone.2015.04.036.
3
Insulin Resistance Negatively Influences the Muscle-Dependent IGF-1-Bone Mass Relationship in Premenarcheal Girls.
J Clin Endocrinol Metab. 2016 Jan;101(1):199-205. doi: 10.1210/jc.2015-3451. Epub 2015 Nov 17.
4
Insulin-Like Growth Factor I Regulation and Its Actions in Skeletal Muscle.
Compr Physiol. 2018 Dec 13;9(1):413-438. doi: 10.1002/cphy.c180010.
5
The ABCs of IGF-I isoforms: impact on muscle hypertrophy and implications for repair.
Appl Physiol Nutr Metab. 2006 Dec;31(6):791-7. doi: 10.1139/h06-054.
6
The therapeutic potential of IGF-I in skeletal muscle repair.
Trends Endocrinol Metab. 2013 Jun;24(6):310-9. doi: 10.1016/j.tem.2013.03.004. Epub 2013 Apr 27.
7
Role of muscle-derived growth factors in bone formation.
J Musculoskelet Neuronal Interact. 2010 Mar;10(1):64-70.
10
Ageing and local growth factors in muscle.
Scand J Med Sci Sports. 2003 Feb;13(1):34-9. doi: 10.1034/j.1600-0838.2003.20235.x.

引用本文的文献

2
Roles of Insulin-Like Growth Factor-1 in Muscle Wasting and Osteopenia in Mice with Hyponatremia.
Calcif Tissue Int. 2025 Apr 14;116(1):61. doi: 10.1007/s00223-025-01369-7.
3
Regulation of Skeletogenic Pathways by m6A RNA Modification: A Comprehensive Review.
Calcif Tissue Int. 2025 Apr 3;116(1):58. doi: 10.1007/s00223-025-01367-9.
5
6
8
Causal associations between the insulin-like growth factor family and sarcopenia: a bidirectional Mendelian randomization study.
Front Endocrinol (Lausanne). 2024 Oct 23;15:1422472. doi: 10.3389/fendo.2024.1422472. eCollection 2024.
10
Bone-muscle crosstalk under physiological and pathological conditions.
Cell Mol Life Sci. 2024 Jul 27;81(1):310. doi: 10.1007/s00018-024-05331-y.

本文引用的文献

1
Hypertrophic chondrocytes can become osteoblasts and osteocytes in endochondral bone formation.
Proc Natl Acad Sci U S A. 2014 Aug 19;111(33):12097-102. doi: 10.1073/pnas.1302703111. Epub 2014 Aug 4.
2
Insulin-like growth factor-II: its role in metabolic and endocrine disease.
Clin Endocrinol (Oxf). 2014 Jun;80(6):773-81. doi: 10.1111/cen.12446. Epub 2014 Mar 24.
3
Viral expression of insulin-like growth factor I E-peptides increases skeletal muscle mass but at the expense of strength.
Am J Physiol Endocrinol Metab. 2014 Apr 15;306(8):E965-74. doi: 10.1152/ajpendo.00008.2014. Epub 2014 Feb 25.
4
IGF-1 regulation of key signaling pathways in bone.
Bonekey Rep. 2013 Oct 2;2:437. doi: 10.1038/bonekey.2013.171.
5
Osteocyte-derived insulin-like growth factor I is essential for determining bone mechanosensitivity.
Am J Physiol Endocrinol Metab. 2013 Jul 15;305(2):E271-81. doi: 10.1152/ajpendo.00092.2013. Epub 2013 May 28.
6
The pro-forms of insulin-like growth factor I (IGF-I) are predominant in skeletal muscle and alter IGF-I receptor activation.
Endocrinology. 2013 Mar;154(3):1215-24. doi: 10.1210/en.2012-1992. Epub 2013 Feb 13.
7
Anabolic effects of IGF-1 signaling on the skeleton.
Front Endocrinol (Lausanne). 2013 Feb 4;4:6. doi: 10.3389/fendo.2013.00006. eCollection 2013.
8
E-peptides control bioavailability of IGF-1.
PLoS One. 2012;7(12):e51152. doi: 10.1371/journal.pone.0051152. Epub 2012 Dec 10.
10
Disruption of the insulin-like growth factor-1 gene in osteocytes impairs developmental bone growth in mice.
Bone. 2013 Jan;52(1):133-44. doi: 10.1016/j.bone.2012.09.027. Epub 2012 Sep 29.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验